SEC Form 4 · accession 0001493152-16-010361

Ernexa Therapeutics Inc. · ERNA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

May 26, 2016

Accepted (ET)

May 26, 2016 · 9:49 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000748592

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	May 26, 2016	P	32,468	$0.1698	A	172,468	I	seefootnote
Common Stock^F1	May 26, 2016	P	15,000	$0.1659	A	187,468	I	seefootnote
Common Stock^F1	May 26, 2016	P	8,497	$0.1697	A	195,965	I	seefootnote
Common Stock^F1	May 26, 2016	P	5,000	$0.1573	A	200,965	I	seefootnote
Common Stock^F1	May 26, 2016	P	1,869	$0.1649	A	202,834	I	seefootnote
Common Stock^F1	May 26, 2016	P	900	$0.166	A	203,734	I	seefootnote
Common Stock^F1	May 26, 2016	P	700	$0.168	A	204,434	I	seefootnote
Common Stock^F1	May 26, 2016	P	500	$0.165	A	204,934	I	seefootnote
Common Stock^F1	May 26, 2016	P	66	$0.15	A	205,000	I	seefootnote

No Table II lines on this filing.